TrialCancer chemotherapy and pharmacology2019

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Fernando Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.